Bryan Hill

Digital

Bryan Hill, life sciences chief technology officer at Cognizant, discusses how generative AI is revolutionising drug development in a new podcast.

News

Chiesi has boosted its rare disease business with an agreement to buy KalVista and Ekterly, its oral drug for treating attacks in rare disease HAE.

Sales & Marketing

As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.